Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
SETD2 mutation
Description:
A genetic alteration in the SETD2 gene, investigated in cancer for its effects on tumor biology, prognosis, and treatment response.
Primary topic:
Renal cell carcinoma treatment (24%)
Related topics:
Renal cell carcinoma treatment (24%),
Lymphoma Diagnosis and Treatment (8%),
Acute Myeloid Leukemia Research (8%),
Glioma Diagnosis and Treatment (7%)
OpenAlex ID:
keywords/setd2-mutation
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
2015
·
The Cancer Genome Atlas Research Network
·
New England Journal of Medicine
·
1,435
PDF
Radiogenomics of Clear Cell Renal Cell Carcinoma: Associations between CT Imaging Features and Mutations
2013
·
Christoph A. Karlo
, Pier Luigi Di Paolo
, et al.
·
Radiology
·
280
Automated real-world data integration improves cancer outcome prediction
2024
·
Justin Jee
, Christopher Fong
, et al.
·
Nature
·
241
Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma
2019
·
Jake June-Koo Lee
, Seongyeol Park
, et al.
·
Cell
·
238
PDF
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
2016
·
H Kadara
, M Choi
, et al.
·
Annals of Oncology
·
212
PDF
SETD2: an epigenetic modifier with tumor suppressor functionality
2016
·
Jun Li
, Gerben Duns
, et al.
·
Oncotarget
·
180
PDF
Pro-inflammatory and proliferative microglia drive progression of glioblastoma
2021
·
Hailong Liu
, Youliang Sun
, et al.
·
Cell Reports
·
159
Frequent IDH2 R172 mutations in undifferentiated and poorly‐differentiated sinonasal carcinomas
2017
·
Snjezana Dogan
, Deborah J Chute
, et al.
·
The Journal of Pathology
·
135
Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
2020
·
Lisa Quetel
, Clément Meiller
, et al.
·
Molecular Oncology
·
124
PDF
Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors
2018
·
Mariko Yabe
, Roberto N. Miranda
, et al.
·
Human Pathology
·
105
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome
2022
·
Luis Veloza
, Doriane Cavalieri
, et al.
·
Haematologica
·
92
PDF
Histone methyltransferase SETD2: a potential tumor suppressor in solid cancers
2020
·
Rui Chen
, Wei-qing Zhao
, et al.
·
Journal of Cancer
·
89
PDF
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
2016
·
H Parker
, M J J Rose-Zerilli
, et al.
·
Leukemia
·
88
PDF
Construction of immune‐related risk signature for renal papillary cell carcinoma
2018
·
Zhongyu Wang
, Qian Song
, et al.
·
Cancer Medicine
·
80
PDF
Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma
2018
·
Gerard K. Nguyen
, Vincent M. Mellnick
, et al.
·
Radiology
·
66
CRTC 1– MAML 2 fusion in mucoepidermoid carcinoma of the breast
2018
·
Gregory R Bean
, Gregor Krings
, et al.
·
Histopathology
·
56
PDF
SETD2 mutations confer chemoresistance in acute myeloid leukemia partly through altered cell cycle checkpoints
2019
·
Yunzhu Dong
, Xinghui Zhao
, et al.
·
Leukemia
·
52
PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways
2015
·
Chenchen Feng
, Yang Sun
, et al.
·
Scientific Reports
·
51
PDF
Genomic Alterations and Outcomes with VEGF-Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma
2017
·
M.I. Carlo
, B. Manley
, et al.
·
Kidney Cancer
·
50
PDF
SETD2 mutations in primary central nervous system tumors
2018
·
Angela N. Viaene
, Mariarita Santi
, et al.
·
Acta Neuropathologica Communications
·
46
PDF
Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing
2016
·
Riccardo Masetti
, Ilaria Castelli
, et al.
·
Oncotarget
·
36
PDF
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma
2022
·
Lauren C. Peres
, Christelle M. Colin-Leitzinger
, et al.
·
Blood Advances
·
33
PDF
T and NK cell abundance defines two distinct subgroups of renal cell carcinoma
2022
·
Moon Hee Lee
, Petrus Järvinen
, et al.
·
OncoImmunology
·
33
RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancer
2023
·
Hong-Tao Li
, H. Josh Jang
, et al.
·
Cell Reports
·
32
PDF
The role of RB1 alteration and 4q12 amplification in IDH-WT glioblastoma
2021
·
Antonio Dono
, Arvind V Ramesh
, et al.
·
Neuro-Oncology Advances
·
31
PDF
Show more works
View as search
Works count:
232
Citation count:
5,004
Year
Topic
Type